<p>*Disease classification/severity defined as MPS I—Hurler, Hurler-Scheie, Scheie; MPS II—severe = neuronopathic, attenuated = non-neuronopathic.</p><p>Demographic characteristics of 16 patients with mucopolysaccharidoses.</p
Abstract Mucopolysaccharidosis type II (MPS II) is a rare genetic, multiorgan disease. Little inform...
In this study, we aimed to describe the natural history of mucopolysaccharidosis I
<p>EP, epithelioid; SA, sarcomatoid; BI, Biphasic; S-I (any T1a, any ...
Aim: Mucopolysaccharidoses (MPSs) are a group of lysosomal storage disorders caused by the deficienc...
Approximately two-thirds of patients with mucopolysaccharidosis II (MPS II; Hunter syndrome) have ne...
Abstract Background Mucopolysaccharidosis type I (MPS I) is traditionally divided into three phenoty...
Demographic and clinical characteristics of patients infected with RNA viruses, DNA viruses, M. pneu...
Abstract Mucopolysaccharidoses (MPS) are a group of lysosomal multisystemic, chronic, and progressiv...
Demographic characteristics of patients and manifestations of stroke (n = 195).</p
Abstract. The mucopolysaccharidoses (MPS) are a group of lysosomal storage disorders characterized b...
Abstract Background Mucopolysaccharidosis type I (MPS I) is a rare lysosomal storage disease subdivi...
<p>Demographic characteristics of patients with blood stream infection or intracranial infection.</p
Background: The phenotypic spectrum of many rare disorders is much wider than previously considered....
Mucopolysaccharidosis VII (MPS VII) is an ultra-rare disease characterised by the deficiency of β-gl...
<p>Demographics, comorbidities and neurological symptoms of 312 patients with polyneuropathy.</p
Abstract Mucopolysaccharidosis type II (MPS II) is a rare genetic, multiorgan disease. Little inform...
In this study, we aimed to describe the natural history of mucopolysaccharidosis I
<p>EP, epithelioid; SA, sarcomatoid; BI, Biphasic; S-I (any T1a, any ...
Aim: Mucopolysaccharidoses (MPSs) are a group of lysosomal storage disorders caused by the deficienc...
Approximately two-thirds of patients with mucopolysaccharidosis II (MPS II; Hunter syndrome) have ne...
Abstract Background Mucopolysaccharidosis type I (MPS I) is traditionally divided into three phenoty...
Demographic and clinical characteristics of patients infected with RNA viruses, DNA viruses, M. pneu...
Abstract Mucopolysaccharidoses (MPS) are a group of lysosomal multisystemic, chronic, and progressiv...
Demographic characteristics of patients and manifestations of stroke (n = 195).</p
Abstract. The mucopolysaccharidoses (MPS) are a group of lysosomal storage disorders characterized b...
Abstract Background Mucopolysaccharidosis type I (MPS I) is a rare lysosomal storage disease subdivi...
<p>Demographic characteristics of patients with blood stream infection or intracranial infection.</p
Background: The phenotypic spectrum of many rare disorders is much wider than previously considered....
Mucopolysaccharidosis VII (MPS VII) is an ultra-rare disease characterised by the deficiency of β-gl...
<p>Demographics, comorbidities and neurological symptoms of 312 patients with polyneuropathy.</p
Abstract Mucopolysaccharidosis type II (MPS II) is a rare genetic, multiorgan disease. Little inform...
In this study, we aimed to describe the natural history of mucopolysaccharidosis I
<p>EP, epithelioid; SA, sarcomatoid; BI, Biphasic; S-I (any T1a, any ...